Log in to save to my catalogue

Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?

Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8978805

Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?

About this item

Full title

Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Clinical oncology, 2021-05, Vol.18 (5), p.261-279

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The immune system has crucial roles in cancer development and treatment. Whereas adaptive immunity can prevent or constrain cancer through immunosurveillance, innate immunity and inflammation often promote tumorigenesis and malignant progression of nascent cancer. The past decade has witnessed the translation of knowledge derived from preclinical s...

Alternative Titles

Full title

Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8978805

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8978805

Other Identifiers

ISSN

1759-4774

E-ISSN

1759-4782

DOI

10.1038/s41571-020-00459-9

How to access this item